首页 > 最新文献

Current Cardiovascular Risk Reports最新文献

英文 中文
Homelessness, Race/Ethnicity, and Cardiovascular Disease: a State-of-the-Evidence Summary and Structured Review of Race/Ethnicity Reporting 无家可归、种族/民族和心血管疾病:种族/民族报告的最新证据总结和结构化审查
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-08-16 DOI: 10.1007/s12170-023-00725-2
Phillippe F. Nyembo, C. Bakker, W. Ayenew, G. Shroff, Andrew M. Busch, K. Vickery
{"title":"Homelessness, Race/Ethnicity, and Cardiovascular Disease: a State-of-the-Evidence Summary and Structured Review of Race/Ethnicity Reporting","authors":"Phillippe F. Nyembo, C. Bakker, W. Ayenew, G. Shroff, Andrew M. Busch, K. Vickery","doi":"10.1007/s12170-023-00725-2","DOIUrl":"https://doi.org/10.1007/s12170-023-00725-2","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"167 - 176"},"PeriodicalIF":1.9,"publicationDate":"2023-08-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"53316982","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does GLP-RA Plus an SGLT2 Inhibitor Yield Greater Weight Loss in Patients with Obesity and Diabetes than Monotherapy? GLP-RA加SGLT2抑制剂对肥胖和糖尿病患者的减肥效果是否比单一治疗更大?
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-08-08 DOI: 10.1007/s12170-023-00724-3
Caraline Watkins, Zoe Schilling, Kevin Kawalec, Darrell Hulisz
{"title":"Does GLP-RA Plus an SGLT2 Inhibitor Yield Greater Weight Loss in Patients with Obesity and Diabetes than Monotherapy?","authors":"Caraline Watkins, Zoe Schilling, Kevin Kawalec, Darrell Hulisz","doi":"10.1007/s12170-023-00724-3","DOIUrl":"https://doi.org/10.1007/s12170-023-00724-3","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"155 - 165"},"PeriodicalIF":1.9,"publicationDate":"2023-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"42193961","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Next Generation ECG: The Impact of Artificial Intelligence and Machine Learning 新一代心电图:人工智能和机器学习的影响
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-07-22 DOI: 10.1007/s12170-023-00723-4
G. Adasuriya, S. Haldar
{"title":"Next Generation ECG: The Impact of Artificial Intelligence and Machine Learning","authors":"G. Adasuriya, S. Haldar","doi":"10.1007/s12170-023-00723-4","DOIUrl":"https://doi.org/10.1007/s12170-023-00723-4","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"143 - 154"},"PeriodicalIF":1.9,"publicationDate":"2023-07-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48801333","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Hybrid Ablation Procedures of Atrial Fibrillation—How to Optimize Patient Selection and Improve the Procedural Approach 房颤混合消融手术——如何优化患者选择和改进手术方法
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-06-19 DOI: 10.1007/s12170-023-00722-5
D. D. De Lurgio, M. Meador
{"title":"Hybrid Ablation Procedures of Atrial Fibrillation—How to Optimize Patient Selection and Improve the Procedural Approach","authors":"D. D. De Lurgio, M. Meador","doi":"10.1007/s12170-023-00722-5","DOIUrl":"https://doi.org/10.1007/s12170-023-00722-5","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"133 - 141"},"PeriodicalIF":1.9,"publicationDate":"2023-06-19","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45989403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Neuromodulation for the Management of Atrial Fibrillation—How to Optimize Patient Selection and the Procedural Approach 心房颤动的神经调节治疗——如何优化患者选择和手术方法
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-31 DOI: 10.1007/s12170-023-00718-1
D. Soltani, S. Stavrakis
{"title":"Neuromodulation for the Management of Atrial Fibrillation—How to Optimize Patient Selection and the Procedural Approach","authors":"D. Soltani, S. Stavrakis","doi":"10.1007/s12170-023-00718-1","DOIUrl":"https://doi.org/10.1007/s12170-023-00718-1","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"91 - 102"},"PeriodicalIF":1.9,"publicationDate":"2023-03-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44086660","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity and Cardiovascular Risk among South Asian Americans. 南亚裔美国人的肥胖症和心血管风险。
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-03-01 Epub Date: 2023-02-03 DOI: 10.1007/s12170-023-00714-5
Ashwini Deshpande, Nilay S Shah, Namratha R Kandula

Purpose of review: South Asian Americans experience higher cardiometabolic risk and disproportionately high rates of cardiovascular disease (CVD) compared to other racial and ethnic groups in the United States. The purpose of this review is to summarize recent evidence about the role of obesity in CVD risk in South Asian Americans and identify key evidence gaps and future directions for research and interventions for obesity in this group.

Recent findings: South Asian Americans are predisposed to abdominal obesity and have a higher distribution of visceral fat, intermuscular fat, and intrahepatic fat compared to adults of other race and ethnic groups. In this population, the risk for cardiometabolic disease appears to be elevated even at a normal body mass index. Social, cultural, religious, interpersonal, and environmental factors are related to obesity and obesity-related behaviors among South Asian Americans.

Summary: There is a relatively high prevalence of obesity in South Asian-origin populations in the United States, who have unique socio-cultural determinants of overweight and obesity. Future research should clarify why the risk for metabolic disease and CVD is elevated at normal BMI in the South Asian American population, and environmental and other structural factors that may influence obesity in this group. Interventions must be adapted to the social and cultural context of South Asian Americans to improve effectiveness and implementation.

综述目的:与美国其他种族和族裔群体相比,南亚裔美国人的心脏代谢风险更高,心血管疾病(CVD)发病率也高得不成比例。本综述旨在总结有关肥胖在南亚裔美国人心血管疾病风险中的作用的最新证据,并确定该群体肥胖研究和干预的主要证据差距和未来方向:与其他种族和族裔的成年人相比,南亚裔美国人容易腹部肥胖,内脏脂肪、肌间脂肪和肝内脂肪的分布较高。在这一人群中,即使体重指数正常,罹患心脏代谢疾病的风险似乎也会升高。社会、文化、宗教、人际关系和环境因素与南亚裔美国人的肥胖症和肥胖相关行为有关。未来的研究应阐明为什么南亚裔美国人在体重指数正常的情况下患代谢性疾病和心血管疾病的风险会升高,以及可能影响该群体肥胖的环境因素和其他结构性因素。干预措施必须适应南亚裔美国人的社会和文化背景,以提高有效性和实施效果。
{"title":"Obesity and Cardiovascular Risk among South Asian Americans.","authors":"Ashwini Deshpande, Nilay S Shah, Namratha R Kandula","doi":"10.1007/s12170-023-00714-5","DOIUrl":"10.1007/s12170-023-00714-5","url":null,"abstract":"<p><strong>Purpose of review: </strong>South Asian Americans experience higher cardiometabolic risk and disproportionately high rates of cardiovascular disease (CVD) compared to other racial and ethnic groups in the United States. The purpose of this review is to summarize recent evidence about the role of obesity in CVD risk in South Asian Americans and identify key evidence gaps and future directions for research and interventions for obesity in this group.</p><p><strong>Recent findings: </strong>South Asian Americans are predisposed to abdominal obesity and have a higher distribution of visceral fat, intermuscular fat, and intrahepatic fat compared to adults of other race and ethnic groups. In this population, the risk for cardiometabolic disease appears to be elevated even at a normal body mass index. Social, cultural, religious, interpersonal, and environmental factors are related to obesity and obesity-related behaviors among South Asian Americans.</p><p><strong>Summary: </strong>There is a relatively high prevalence of obesity in South Asian-origin populations in the United States, who have unique socio-cultural determinants of overweight and obesity. Future research should clarify why the risk for metabolic disease and CVD is elevated at normal BMI in the South Asian American population, and environmental and other structural factors that may influence obesity in this group. Interventions must be adapted to the social and cultural context of South Asian Americans to improve effectiveness and implementation.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 3","pages":"73-82"},"PeriodicalIF":1.9,"publicationDate":"2023-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10063226/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9542513","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Genetics of Mitochondrial Cardiomyopathy 线粒体心肌病的遗传学
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-02-10 DOI: 10.1007/s12170-023-00715-4
A. Towheed, A. Goldstein
{"title":"Genetics of Mitochondrial Cardiomyopathy","authors":"A. Towheed, A. Goldstein","doi":"10.1007/s12170-023-00715-4","DOIUrl":"https://doi.org/10.1007/s12170-023-00715-4","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"49 - 72"},"PeriodicalIF":1.9,"publicationDate":"2023-02-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43102682","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Overview of the Risks of Contemporary Energy Drink Consumption and Their Active Ingredients on Cardiovascular Events 当代能量饮料及其活性成分对心血管事件的风险综述
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-02-09 DOI: 10.1007/s12170-023-00716-3
Kaden T. Bunch, MAREN B. Peterson, Megan B. Smith, T. Bunch
{"title":"An Overview of the Risks of Contemporary Energy Drink Consumption and Their Active Ingredients on Cardiovascular Events","authors":"Kaden T. Bunch, MAREN B. Peterson, Megan B. Smith, T. Bunch","doi":"10.1007/s12170-023-00716-3","DOIUrl":"https://doi.org/10.1007/s12170-023-00716-3","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"39 - 48"},"PeriodicalIF":1.9,"publicationDate":"2023-02-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41420043","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of Pharmacogenetics for the Use of Antiplatelet and Anticoagulant Drugs 药物遗传学在抗血小板和抗凝药物应用中的应用
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-10 DOI: 10.1007/s12170-022-00713-y
S. Tuteja
{"title":"Application of Pharmacogenetics for the Use of Antiplatelet and Anticoagulant Drugs","authors":"S. Tuteja","doi":"10.1007/s12170-022-00713-y","DOIUrl":"https://doi.org/10.1007/s12170-022-00713-y","url":null,"abstract":"","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 1","pages":"27-38"},"PeriodicalIF":1.9,"publicationDate":"2023-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48034120","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Remote Patient Monitoring: What Have We Learned and Where Are We Going? 远程患者监测:我们学到了什么?我们要去哪里?
IF 1.9 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS Pub Date : 2023-01-01 Epub Date: 2023-04-22 DOI: 10.1007/s12170-023-00720-7
Bert Vandenberk, Satish R Raj

Purpose of review: Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is an important part of patient follow-up. The increasing number of patients with CIEDs and the recent pandemic pose several challenges for already limited device clinic resources. This review focuses on recent evolutions in RM and identifies future needs to improve RM.

Recent findings: RM has been associated with multiple clinical benefits, including improved survival, early detection of actionable events, reduction in inappropriate shocks, longer battery lives, and more efficient healthcare utilization. The survival benefit was driven by studies using alert-based continuous RM with daily transmissions and fast reaction times. Patients report a high satisfaction rate without significant differences in quality of life between RM and in-office follow-up.The increasing workload, due to the increasing number of CIEDs implanted with daily remote transmissions, results in several challenges for the future of RM. RM requires appropriate reimbursement for RM device clinics to optimize patient/staff ratios, including sufficient non-clinical and administrative support. Universal alert programming and data processing may minimize inter-manufacturer differences, improve the signal-to-noise ratio, and allow the development of standard operating protocols and workflows. In the future, programming by remote control and true remote programming may further improve remote CIED management, patient quality of life, and device clinic workflows.

Summary: RM should be considered standard of care in management of patients with CIEDs. The clinical benefits of RM can be maximized by an alert-based continuous RM model. Adapted healthcare policies are required to keep RM manageable for the future.

综述目的:心脏植入式电子设备(CIED)的远程监测(RM)是患者随访的重要组成部分。CIED患者数量的增加和最近的疫情给本已有限的设备诊所资源带来了一些挑战。这篇综述的重点是RM的最新发展,并确定了改进RM的未来需求。最近的发现:RM具有多种临床益处,包括提高生存率、早期发现可操作事件、减少不适当电击、延长电池寿命和更有效的医疗利用率。使用基于警报的连续RM进行的研究推动了生存效益,该RM具有每日传播和快速反应时间。患者报告称,RM和办公室随访之间的生活质量没有显著差异,满意度很高。由于每天远程传输的CIED数量不断增加,工作量不断增加,这给RM的未来带来了一些挑战。RM需要对RM设备诊所进行适当的报销,以优化患者/员工比例,包括足够的非临床和行政支持。通用警报编程和数据处理可以最大限度地减少制造商之间的差异,提高信噪比,并允许开发标准操作协议和工作流程。未来,通过远程控制和真正的远程编程进行编程可能会进一步改善远程CIED管理、患者生活质量和设备诊所工作流程。总结:在CIEDs患者的管理中,RM应被视为护理标准。RM的临床效益可以通过基于警报的连续RM模型最大化。需要调整医疗保健政策,以保持RM在未来的可管理性。
{"title":"Remote Patient Monitoring: What Have We Learned and Where Are We Going?","authors":"Bert Vandenberk,&nbsp;Satish R Raj","doi":"10.1007/s12170-023-00720-7","DOIUrl":"10.1007/s12170-023-00720-7","url":null,"abstract":"<p><strong>Purpose of review: </strong>Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is an important part of patient follow-up. The increasing number of patients with CIEDs and the recent pandemic pose several challenges for already limited device clinic resources. This review focuses on recent evolutions in RM and identifies future needs to improve RM.</p><p><strong>Recent findings: </strong>RM has been associated with multiple clinical benefits, including improved survival, early detection of actionable events, reduction in inappropriate shocks, longer battery lives, and more efficient healthcare utilization. The survival benefit was driven by studies using alert-based continuous RM with daily transmissions and fast reaction times. Patients report a high satisfaction rate without significant differences in quality of life between RM and in-office follow-up.The increasing workload, due to the increasing number of CIEDs implanted with daily remote transmissions, results in several challenges for the future of RM. RM requires appropriate reimbursement for RM device clinics to optimize patient/staff ratios, including sufficient non-clinical and administrative support. Universal alert programming and data processing may minimize inter-manufacturer differences, improve the signal-to-noise ratio, and allow the development of standard operating protocols and workflows. In the future, programming by remote control and true remote programming may further improve remote CIED management, patient quality of life, and device clinic workflows.</p><p><strong>Summary: </strong>RM should be considered standard of care in management of patients with CIEDs. The clinical benefits of RM can be maximized by an alert-based continuous RM model. Adapted healthcare policies are required to keep RM manageable for the future.</p>","PeriodicalId":46144,"journal":{"name":"Current Cardiovascular Risk Reports","volume":"17 6","pages":"103-115"},"PeriodicalIF":1.9,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10122094/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9976423","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Current Cardiovascular Risk Reports
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1